TechFlow reported on February 19, according to Globe Newswire, that Nasdaq-listed biopharmaceutical company Quantum BioPharma (NASDAQ: QNTM) announced it has increased its holdings in Bitcoin and other cryptocurrencies by $1 million, approved by the board of directors, bringing its total cryptocurrency holdings to $2 million.
The company stated this move aims to generate investment returns for shareholders and hedge against Canadian dollar risks. The company has completed the deployment of its cryptocurrency payment system and will accept cryptocurrency for financing and other transactions in the future. All cryptocurrency assets are held by compliant custodians to ensure adherence to relevant financial and auditing regulations.
Add to Favorites
Share to Social Media
